Translarna AdCom Has DMD Experience, But Most Opposed Approval Of Prior Applications

 
• By Derrick Gingery
  
FDA Advisory Committee Feature image
Advisory committee members will review another proposed Duchenne muscular dystrophy drug on Sept. 28.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers